PrEP (HIV Pre-Exposure Prophylaxis)

The Latest

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

By Kenyon Farrow

New Website Helps People Trying to Navigate Their PrEP Options

A team led by Shannon Weber, M.S.W., has developed PleasePrEPMe, an online PrEP provider search and chat service.

By Terri Wilder, M.S.W.

Are Urgent Care Centers Prescribing PrEP? Researchers Explore the Answer

A new CDC study suggests that many urgent care centers in the U.S. still need to be made aware of pre-exposure prophylaxis and how to provide it.

By Terri Wilder, M.S.W.

Primary Care Providers Aware of PrEP in NYC Suburbs, but Report Barriers to Prescribing

Anthony J. Santella, Dr.P.H., explains why prevention efforts are lagging within the largest suburban HIV epidemic in the U.S.

By Terri Wilder, M.S.W.

This Week in HIV Research: From PrEP to Treatment, There's Always More to Learn

April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.

By Barbara Jungwirth and Myles Helfand

PrEP Use Is Correlated With an Increase in STIs, JAMA Study Finds

However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.

By Sony Salzman

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

By Barbara Jungwirth and Myles Helfand

Results of CDC-Funded Local Projects for MSM and Transgender People Unveiled at Prevention Conference

Project PrIDE demonstration studies in New York and Houston show that properly funded and well-designed outreach programs can impact a city's ability to provide better HIV services for underserved populations.

By Sony Salzman

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs

Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.

By Sony Salzman

Chemsex Doesn't Impact PrEP Adherence, New Study Finds

Although people living with HIV who "party and play" appear more likely to struggle with treatment adherence, new research suggests that concern does not apply to PrEP.

By Sony Salzman